Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[The biological point of view on pharmacogenetics of anticancer agents in colorectal cancer].

Bulletin du cancer - 1 Oct 2008

Laurent-Puig Pierre, Lièvre Astrid, Ducreux Michel, Loriot Marie-Anne

Abstract excerpt

Several drugs have been developed and demonstrated similar efficacy in colorectal cancer treatment therefore with choice, time comes for decision. The biologist will have to provide the tools allowing to clarify this choice. Among the tools available, those of pharmacogenetics and pharmacogenomic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Camptothecin
Share to Cyclin D1
Share to Dihydrouracil Dehydrogenase (NADP)

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Epidermal Growth Factor

Share to Irinotecan

Share to Organoplatinum Compounds

Share to Receptors, IgG

Share to Thymidylate Synthase

Source

Identifiers

PMID: 19004723
DOI: 10.1684/bdc.2008.0728

Genes

EGFR
KRAS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19004723-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[The biological point of view on pharmacogenetics of anticancer agents in colorectal cancer].PMID 19004723Read ↗

[Recent developments of pharmacogenomics in the treatment of colorectal cancers].Semantic proximity Read ↗

[Pharmacogenetics of anticancer drugs].Semantic proximity Read ↗

[Pharmacogenetics of anti-cancer drugs].Semantic proximity Read ↗

On the use of pharmacogenetics in cancer treatment and clinical trials.Semantic proximity Read ↗

[Interest of UGT1A1 genotyping within digestive cancers treatment by irinotecan].Semantic proximity Read ↗

Pharmacogenetics research on chemotherapy resistance in colorectal cancer over the last 20 yearsSemantic proximity Read ↗

Pharmacogenetic approach for cancer treatment-tailored medicine in practice.Semantic proximity Read ↗

Pharmacogenetics of IrinotecanSemantic proximity Read ↗

<i><scp>UGT</scp>1A1</i> genotype and irinotecan therapy: general review and implementation in routine practiceSemantic proximity Read ↗

UGT1A1 genotyping: a predictor of irinotecan-associated side effects and drug efficacy?Semantic proximity Read ↗

[Drug therapy at the beginning of the genomic era].Semantic proximity Read ↗

Irinotecan toxicity: genes or intestinal microflora?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.